FDA approves Medtronic's blood oxygenator:
This article was originally published in Clinica
Medtronic's Maxima Forte blood oxygenator has been approved by the FDA for marketing in the US. The device is designed to relieve the respiratory function of the lungs during open heart surgery. It defines the shape and dimension of the blood path to avoid turbulence and because the device is significantly smaller than its predecessor, Medtronic's Maxima blood oxgenator, it requires a lot less blood to fill it and become operational. Medtronic, based in Minneapolis, Minnesota, is selling the device for $700.